Oral Live Cholera Vaccines Market Size, Share, Growth, and Industry Analysis, By Type (Euvichol- Plus, DUKORAL, Shanchol, & Others), By Application (Prevention, Emergency Response), Regional Insights and Forecast From 2025 To 2033

• 

  Request a Free sample to learn more about this report

ORAL LIVE CHOLERA VACCINES MARKET OVERVIEW

The global oral live cholera vaccines market size was valued at approximately USD 0.09 billion in 2024 and is projected to grow USD 0.17 billion by 2033, with exhibiting a CAGR of 7% during the forecast period 2025 to 2033.

Oral Live Cholera vaccines protect against cholera. Cholera is a diarrheal illness which is caused by Vibrio cholerae. These vaccines are given by mouth, and they contain weakened strains of the cholera bacteria that stimulate the immune system without causing the disease. These vaccines help in inducing mucosal and systemic immunity, giving protection for several years. Take the example of Vaxchora, a single-dose liquid, which is convenient and effective, especially in endemic regions, offering rapid immunity. Professionals keep these vaccines in proper storage to maintain potency, as they are very important for travellers, emergency responders, and populations in cholera-affected areas, contributing to public health betterment.

The Oral Live Cholera Vaccine Market is targeting the need to control cholera outbreaks, especially in endemic regions such as Africa and South Asia. The key players in the market are producing vaccines, making people aware of the danger and with the help of government and organisations such as WHO and UNICEF, they are expanding their reach. The advancement in vaccine technology and rising travel to cholera-prone areas is influencing the market, pushing it to higher levels. Some challenges such as cold chain logistics and the need for widespread immunisation are pushing the market back.

COVID-19 IMPACT

Market Growth Declined by Pandemic Due to Healthcare Shift

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic affected the market due to the shift in another health-related issues such as the virus. A maximum number of resources and funding that were allocated to cholera vaccination programs were redirected to manage and reduce the spread of the COVID-19 virus. This reallocation led to a reduction in cholera vaccination coverage. The regions which were highly affected faced a decline in product supply. With the rising importance of the pandemic, the planned rollouts of new cholera vaccination campaigns were also delayed which has eventually resulted in an increased urgency in rebalancing public health efforts to address cholera effectively.

LATEST TRENDS

Advancement in campaigns in market promotion to Drive Market Growth

The vaccine market has digitalised itself by integrating digital health technology to improve vaccination campaigns. Companies are offering mobile health apps and digital platforms that are being utilised to track vaccination coverage, schedule immunization, and provide education on cholera prevention. These technologies are offering smooth accessibility and efficiency, especially in remote or underserved areas. The advanced features are providing better data collection and monitoring, helping public health officials respond more swiftly to outbreaks. The trend has generated the automated move towards leveraging digital solutions to enhance public health initiatives and ensure wider and more effective distribution of cholera vaccines.

Request a Free sample to learn more about this report

ORAL LIVE CHOLERA VACCINES MARKET SEGMENTATION

By Type

Based on type the global market can be categorized into Euvichol- Plus, DUKORAL, Shanchol

• Euvichol-Plus: This is a bivalent cholera vaccine that protects against the O1 and O139 of Vibrio cholerae. Given in a single-dose, prefilled, and heat-stable vial, particularly suited for mass vaccination campaigns. It is a liquid formulation making it easy to take and widely used in pandemic-prone areas.

• DUKORAL: DUKORAL is an inactivated oral cholera vaccine that targets the O1 serogroup of Vibro cholerae, where it kills whole-cell components and a recombinant cholera toxin B subunit. It will be given in two doses mixed with a buffer solution, generally used by travellers to cholera-affected regions and residents of endemic areas. This vaccine offers protection against enterotoxigenic Escherichia coli (ETEC), which generally causes traveller’s diarrhoea.

• Shanchol: Shanchol is a bivalent oral cholera vaccine that targets both O1 and O139 serogroups of Vibro cholerae. It will given in two doses with a gap of two weeks, ensuring effective immunisation against cholera. It is widely used in cholera-endemic countries for routine immunisation and during outbreak responses. This vaccine is affordable and can be easily taken making it a most preferable choice for large-scale public health interventions.

By Application

Based on application the global market can be categorized into Prevention, Emergency Response.

• Prevention: Cholera vaccine provides long-term protection, helping keep cholera levels low. These vaccines are used to immunise people in areas where cholera is common, as a part of regular public health programs, with the motive of reducing cholera outbreaks. They protect areas with poor sanitation, to prevent the spread of the disease.

• Emergency Response: Whenever a sudden outbreak occurs, cholera vaccines are important for areas facing natural disasters, refugee crises, or conflict. These vaccines are smoothly deployed to immunise at-risk populations and halt cholera’s rapid spread. These vaccines can be given on a large scale under tough conditions making them essential in global efforts to control cholera.

DRIVING FACTORS

Public Health Initiatives and Global Cholera Burden to Boost the Market

Governments are taking initiatives to improve public health and reduce the burden of infectious diseases such as cholera. The market is getting the required attention from authorities. This has led to enhanced vaccination campaigns targeting high-risk populations in endemic regions and emergency responses during outbreaks, helping people and making others aware, leading to Oral Live Cholera Vaccines Market Growth.

The persistent global burden of cholera generally can be found in developing countries with inadequate sanitation and clean water access, driving the demand for effective vaccines. The world is facing high incidence rates due to which the authorities and industries are investing huge amounts in vaccination programs as part of comprehensive cholera control strategies, eventually propelling the vaccine market growth.

Vaccine Technology and International Health Regulations to Expand the Market

With growing innovation in vaccine development and delivery systems, the market is witnessing improved efficacy, safety, and affordability of oral live cholera vaccines. These advancements are causing a wave of investment from pharmaceutical companies and support wider adoption in diverse geographic and demographic regions, causing a significant rise in Oral Live Cholera Vaccines Market Growth.

Compliance with international health regulations and recommendations from organisations such as the World Health Organisation (WHO) and UNICEF, is helping push countries to integrate oral cholera vaccine into national immunisation schedules, and this support is directly benefiting the market by standardizing vaccine use with growing access in vulnerable populations.

RESTRAINING FACTORS

Logistical Challenges and Vaccine Hesitancy to Potentially Impede Market Growth

The Market is facing challenges in fulfilling the logistics requirements such as cold chain storage and transportation. This issue generally arises in resource-limited areas where maintaining consistent cold storage infrastructure can be difficult. This logistical complexity will increase the cost and can hinder the timely distribution of vaccines to remote or rural areas, impacting the overall vaccination market and its coverage.

Vaccine hesitancy is a major hurdle in the healthcare sector. Misinformation or lack of information in immunisation can reduce vaccine uptake even in areas where cholera is endemic. In some regions, cultural or religious beliefs, as well as concerns about vaccine safety and efficacy, may be creating misleading influence among communities and stopping them from acceptance.

• Request a Free sample to learn more about this report

•  

ORAL LIVE CHOLERA VACCINES MARKET REGIONAL INSIGHTS

North America Region Dominating the Market due to the Presence of a Robust Healthcare Infrastructure

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

North America is the global leader and highest holder of the Oral Live Cholera Vaccines Market. The region has a strong healthcare infrastructure, high healthcare expenditure, and advanced research capabilities. Companies and healthcare industries of the region are taking part actively in public health, doing vaccination campaigns and emergency preparedness, and improving their leadership in cholera prevention and control. Regulatory bodies are supporting with approvals and distribution of vaccines, propelling the market dominance. North America is claiming the dominating position due to its ability to effectively manage outbreaks and provide timely access to vaccines, contributing at the global level.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Innovation and Market Expansion

Key industry players are reshaping the Oral Live Cholera Vaccines Market through their innovation and market expansion strategies. They are focusing on improving vaccine efficacy, accessibility, and global reach. The key players are mainly pharmaceutical companies and research institutes, that are committed to creating advanced vaccine technology and making innovative efforts to develop more effective formulations, such as bivalent vaccines which are created in a way that will target multiple Vibrio Cholera Serogroups, and enhance vaccine stability for easier distribution in resource-limited regions. These players are expanding their market by increasing their production capacities, establishing strategic partnerships for distribution, and taking the right direction to ensure widespread vaccine availability. These players are driving market growth by improving vaccination coverage and addressing global cholera prevention and control challenges.

List Of Top Oral Live Cholera Vaccines Companies

• PaxVax (U.S.)
• Sanofi (France)
• Valneva (France)
• EuBiologics (South Korea)
• Shanghai United Cell Biotechnology (China)
• Vabiotech (Vietnam)

INDUSTRIAL DEVELOPMENT

June 2024: Belharra Therapeutics has announced that it has entered a strategic partnership with global powerhouse Sanofi to spur the development of small molecule therapies for immunological diseases. Under the terms of the agreement, the San Diego, California-based next-generation chemoproteomics company will receive an upfront payment of $40m. Moreover, the company is in a position to gain up to $700m in payments for research, development, commercial milestones, and royalties over the long term, as per the 18 June press release.

REPORT COVERAGE

This report is based on historical analysis and forecast calculation that aims to help readers get a comprehensive understanding of the global Oral Live Cholera Vaccines Market from multiple angles, which also provides sufficient support to readers’ strategy and decision-making. Also, this study comprises a comprehensive analysis of SWOT and provides insights for future developments within the market. It examines varied factors that contribute to the growth of the market by discovering the dynamic categories and potential areas of innovation whose applications may influence its trajectory in the upcoming years. This analysis encompasses both recent trends and historical turning points into consideration, providing a holistic understanding of the market’s competitors and identifying capable areas for growth.

This research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.